Invention Grant
- Patent Title: Use of ceranib-2 in the treatment of lung cancer
-
Application No.: US15899520Application Date: 2018-02-20
-
Publication No.: US10342790B2Publication Date: 2019-07-09
- Inventor: Hatice Mehtap Kutlu , Gokhan Kus
- Applicant: ANADOLU UNIVERSITESI REKTORLUGU
- Applicant Address: TR Eskisehir
- Assignee: ANADOLU UNIVERSITESI REKTORLUGU
- Current Assignee: ANADOLU UNIVERSITESI REKTORLUGU
- Current Assignee Address: TR Eskisehir
- Agency: Merchant & Gould P.C.
- Priority: TRa201702500 20170220
- Main IPC: A61K31/10
- IPC: A61K31/10 ; A61K31/40 ; A61K31/47 ; A61K31/70 ; A61P35/00 ; A61K31/337 ; A61K31/427 ; A61K31/506 ; A61K31/513 ; A61K31/517 ; A61K31/519 ; A61K31/565 ; A61K31/665 ; A61K31/704 ; A61K31/4188 ; A61K31/4704
Abstract:
The present invention relates to the use of ceranib-2 molecule in the treatment of lung cancer and breast cancer. At the same time, the present invention also describes the in vitro studies made by the inventors in this direction.
Public/Granted literature
- US20180235951A1 USE OF CERANIB-2 IN THE TREATMENT OF LUNG CANCER AND BREAST CANCER Public/Granted day:2018-08-23
Information query
